Biotech · Private company
Angiochem Inc
Track this companyFree. Adds Angiochem Inc to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- ANG1005Phase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- ANG1005Phase 2 · GliomaClinicalTrials.gov · fetched Nov 12, 2026
- BevacizumabPhase 2 · GliomaClinicalTrials.gov · fetched Nov 12, 2026
- GRN1005Phase 2 · Non-small Cell Lung Cancer (NSCLC) With Brain MetastasesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- ANG1005 in Breast Cancer Patients With Recurrent Brain MetastasesPHASE2 · COMPLETED · started Apr 1, 2014ClinicalTrials.gov NCT02048059 · fetched Nov 12, 2026
- ANG1005 in Patients With Recurrent High-Grade GliomaPHASE2 · COMPLETED · started Oct 1, 2013ClinicalTrials.gov NCT01967810 · fetched Nov 12, 2026
- GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)PHASE2 · TERMINATED · started Nov 1, 2011ClinicalTrials.gov NCT01497665 · fetched Nov 12, 2026